Pediatric Primary Care Case Studies (153 page)

blood glucose diaries,
268
t

diabetes,
269
–284

differential,
275
–276,
275
t

history-taking,
267
–268

obesity,
271
–284

physical examination,
268
–269

prediabetes,
270
–271,
271
t

epidemiology/etiology of,
269
–275

Bogalusa Heart Study,
272
–273

DCCT,
274
–275

ERIC,
274

pathophysiology,
269
–271

SEARCH for Diabetes in Youth Study,
272
–274

TODAY Study,
277

TRIGR study,
273
–274

type 1 diabetes,
273
–275,
275
t

type 2 diabetes,
269
–271,
275
t

fundamental contexts of,
267
–268,
284

management of,
270
t,
276
–284

CDC Healthy Weight recommendations,
278
–279

comorbidities,
280
–281

depression,
281

developmental factors,
279
–280

DHHS recommendations,
279

dyslipidemia,
280
–281

education plans,
282
–284

follow-up visits,
284

hypertension,
280

medications,
277
–278

microvascular complications,
281

NDEP,
270
t

nutritional changes,
278
–279

physical activity changes,
279

renal disease,
281

sociocutural factors,
281
–282

therapy goals,
277

treatment options,
277
–278

objectives for,
267

preschoolers and.
See
overweight (preschoolers)

resources for,
270
t

P

Pap smears,
428

ParaGard intrauterine device,
433

parainfluenza virus,
378
,
379
t

parasitic agents,
388

parenteral fluids,
399

paroxetine (Paxil),
215
–219,
217
t

Participation sports examinations.
See
PPEs (participation sports examinations)

Pataday.
See
olopatadine HCl (Patanol, Pataday)

Patanol.
See
olopatadine HCl (Patanol, Pataday)

pathogens

Bordetella pertussis
,
379
t

Campylobacter jejuni
,
388

Chlamydia trachomatis
,
379
t,
382
–383,
382
t

Chlamydophila pneumonia
,
378
–379,
379
t

Entamoeba histolytica
,
388

Escherichia coli
,
388
,
418
,
420

Giardia lamblia
,
388

Haemophilus influenzae
,
349

Klebsiella pneumoniae
,
421

Moraxella catarrhalis
,
349

Mycoplasma pneumoniae
,
377
–385

Propionibacterium acnes
,
472

Salmonella
,
388

Shigella
,
388

Staphylococcus aureus
,
388
,
458
,
469
–470,
487

Streptococcus pneumoniae
,
349
,
378
–379,
379
t,
382
–383,
382
t

transmission of,
384
–395

Paxil.
See
paroxetine (Paxil)

PDD-NOS (pervasive developmental disorder, not otherwise specified),
28

PDDST-II (Pervasive Developmental Disorder Screening Test),
35

pediatric primary care case studies

for developmental problems,
9
–72

fatigue (adolescents),
59
–72

gross motor delays (infants),
11
–26

language/social delays (toddlers),
27
–42

school failure/refusal problems,
43
–58

diagnostic reasoning for,
1
–8

for diseases,
232
–518

acne (adolescents),
467
–480

anemia (toddlers),
291
–320

birth control (adolescents),
427
–440

cough,
377
–386

fever,
233
–250

headache,
321
–335

high blood sugar/overweight,
267
–290

itchy rash,
455
–466

limp,
481
–492

oral trauma,
405
–416

recurrent ear infections (toddlers),
347
–358

red eye (preschoolers),
335
–346

short stature,
507
–518

syncope,
359
–376

urinary urgency/incontinence (preschoolers),
417
–426

vaginal discharge (adolescents),
441
–454

vomiting/diarrhea,
387
–404

well-child care (late-preterm infants),
493
–506

wheezing,
251
–266

for functional/mental health problems,
73
–230

abuse situations,
193
–206

ADHD,
175
–192

breastfeeding/slow weight gain,
103
–114